CASI raises $23.9M in registered direct offering

On Oct. 13, CASI Pharmaceuticals Inc. (NASDAQ:CASI) raised $23.9 million through the sale of 8 million units at $3 in a registered direct offering led by existing stakeholders. Each unit comprises a share and two-and-a-half year warrant to purchase 0.2 shares, with each whole warrant exercisable at $3.75...